Physician profile
Heather A Melton
NPI 1205833142
$9,412.60
in general payments reported to CMS, 2019-2025
20 companies · $3,807 in 2025
The $3,807 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,738 · 2020: $149 · 2021: $328 · 2022: $135 · 2023: $1,102 · 2024: $1,154 · 2025: $3,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,452 · Food and Beverage: $1,445 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,452.38 |
| Food and Beverage | $1,444.78 |
| Education | $165.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,066.96 | 2019-2025 | |
| Gentleman Orthopedic Solutions | $1,703.88 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $1,692.55 | 2024-2025 | Iovera, Exparel, Zilretta |
| Sonex Health, INC. | $1,133.86 | 2025 | Sx-One Microknife |
| Zimmer Biomet Holdings, INC. | $165.82 | 2024 | Persona |
| Pacira Therapeutics, INC. | $155.51 | 2019-2021 | |
| Bioventus LLC | $91.70 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Endo Pharmaceuticals INC. | $68.06 | 2019-2021 | |
| Conformis, INC. | $59.15 | 2020 | |
| Amgen INC. | $51.07 | 2021-2025 | Evenity, Prolia |
| Pfizer INC. | $39.89 | 2019-2020 | |
| Radius Health, INC. | $38.50 | 2019-2025 | Tymlos |
| Heraeus Medical, LLC. | $37.41 | 2021-2022 | |
| Depuy Synthes Sales INC. | $36.76 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $21.95 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $20.79 | 2023 | |
| Ferring Pharmaceuticals INC. | $15.79 | 2019 | |
| Orthofix Medical, INC. | $12.95 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$717,359.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Melton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.